Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinomaM J Hawkins, M B Atkins, J P Dutcher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2002
Anticancer drug discovery and development throughout the worldG Schwartsmann, M J Ratain, G M Cragg, et al.Neuroimage|January 26, 2010
The combined effects on neuronal activation and blood-brain barrier permeability of time and n-3 polyunsaturated fatty acids in mice, as measured in vivo using MEMRIYu-Ting Kuo, Po-Wah So, James R Parkinson, et al.International Journal of Environmental Research and Public Health|February 26, 2025
A Real-World Study on the Quality of Life of Consumers with Dentine Hypersensitivity and the Benefits of Hypersensitivity Toothpaste UseFatimah Maria Tadjoedin, Yuniarti Soeroso, Adityo Widaryono, et al.American Journal of Hematology|August 1, 1987
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2F R Aronson, R A Dempsey, M Allegretta, et al.Cancer Research|July 15, 1991
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trialS C Yang, E A Grimm, D R Parkinson, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCCK Hayakawa, M A Salmeron, D R Parkinson, et al.International Journal of Nanomedicine|September 22, 2017
Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effectsLeigh P Brody, Meliz Sahuri-Arisoylu, James R Parkinson, et al.Journal of the National Cancer Institute|February 19, 1992
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skinS M Lippman, D R Parkinson, L M Itri, et al.Journal of Clinical Immunology|November 1, 1988
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patientsJ W Mier, G Vachino, J W van der Meer, et al.Pageof 15